BSX - Boston Scientific Jumps On Positive Surprise On Farapulse For AFIB Ablation | Benzinga
Signal(s) to enter, add, reduce, exit, hold or change.
News
Boston Scientific (NYSE: BSX) stock is jumping 6.25% to $53.92 as of this writing on a positive surprise from ADVENT study. Farapulse Pulsed Field Ablation is a system in which electric fields selectively ablate heart tissue in patients with atrial fibrillation. The study shows that the system is not inferior to radiofrequency or cryoablation that are now standard-of-care.
Approval
In The Arora Report Analysis, the system is likely to be approved by next year.
Model Portfolio
BSX is in ...